On May 9, 2025, a U.S. District Court granted preliminary approval for a settlement regarding shareholder lawsuits against Emergent BioSolutions Inc., with a final hearing set for August 6, 2025. The settlement involves no admission of fault by the company and was agreed upon through a stipulation dated February 24, 2025.